Every October, awareness campaigns bring breast cancer screening into workplaces and communities across the region. Mobile units, employer programmes and community sessions widen access, and they create a real opportunity for early detection. But an abnormal result begins another journey: further imaging, sometimes a biopsy, and a definitive diagnostic conclusion. Different findings call for different responses, and an abnormal screening result is not itself a cancer diagnosis.
From a health systems perspective, that journey depends on whether responsibility, people, and information are aligned across services that rarely sit within one organisation. Screening reach and timely follow-up should therefore be considered together when assessing a campaign’s success. Three practical requirements make that possible: clear responsibility for following abnormal results, support for women navigating further investigations, and tracking through diagnostic completion.
Connect outreach to the wider system
In Abu Dhabi, Burjeel Cancer Institute’s October mobile mammography campaign brings screening to workplaces and communities across the Emirate. The institute also describes integrated breast-care services combining imaging, surgery, oncology, pathology and support. Initiatives like this reflect real regional commitment, and they show what coordinated outreach and integrated services can achieve. The question is not whether care is being delivered, but how readily its continuity can be seen and strengthened across the many organisations a woman may encounter.
Click here to join our WhatsApp channel here
Connecting outreach to diagnosis involves more than the services available within an individual institution. Women may enter through primary care, employer-supported programmes, community campaigns or specialist facilities, but their subsequent care may cross organisational boundaries. A reliable pathway must therefore accommodate these different entry points and handovers.
Establish responsibility across organisational boundaries
Within a single facility, responsibility for an abnormal screening result may be clear. Across a network, it can become harder to establish who should act when a referral is awaiting acceptance, an appointment has not yet been scheduled, or a patient has not attended.
Health systems need agreed referral arrangements that specify responsibilities at each transition. These should not only cover how results are communicated, but also how patients enter diagnostic services, what information accompanies them, and how unresolved cases are accelerated.
In practical terms, this means a named point of accountability for each abnormal result, an expectation that referrals are acknowledged within an agreed timeframe, and a defined route for escalating cases that are not progressing. Such arrangements work best when they are written down, shared across organisations and reviewed regularly, so that responsibility does not depend on individual goodwill.
Pathways should also reflect clinical need, with clear routes for more urgent assessment.
Where women return to their usual healthcare practitioner after a screening, that practitioner needs access to the relevant result and follow-up plan, so that the woman does not have to relay clinical detail herself, and no one assumes someone else is acting.
Regulators and health authorities can support this through common standards, while providers translate those standards into working arrangements.
Organise navigation around completion
After an abnormal screening, several services may need to act in sequence. Additional imaging informs whether a biopsy is required; pathology informs the clinical conclusion, which must then be communicated to the woman. Supporting patients through this sequence requires a system that connects each step and identifies when progress has stalled.
The World Health Organization’s technical brief on patient navigation describes personalised support to help patients move through complex cancer services. For screening programmes, this means connecting navigation to the recommended follow-up plan. The team supporting a woman should know what assessment is required, whether it has been arranged and communicated, and what remains outstanding.
This gives navigation a concrete operational purpose. If a referral has not been accepted, the receiving service needs to be contacted. If an investigation is awaiting authorisation, the issue needs to reach someone who can resolve it. If a woman misses an appointment, the team should establish why and help her access the recommended care. Responsibility continues until the next step is confirmed. None of this depends on a sophisticated digital platform. Where systems are still developing, a named coordinator, a simple tracking register, and a follow-up call can close the loop, and the same principles apply as services mature.
Unresolved steps also provide useful information. Repeated delays at the same point may indicate a capacity constraint, an unclear handover, or an administrative process that needs adjustment. Reviewing them allows health authorities and providers to address recurring problems while supporting the women affected.
Use information to understand continuity
Counting screening tests provides an important measure of activity, but it does not explain whether women needing further assessment actually reach the next stage of care. Measures need clear definitions. An incomplete examination requiring additional imaging differs from a finding requiring biopsy or planned surveillance. Diagnostic completion should reflect the recommended pathway.
Health systems should be able to track key transitions: communication of results, referral acceptance, attendance for recommended assessment, completion of indicated investigations, and communication of the clinical conclusion. This may require information exchange between organisations, supported by appropriate privacy safeguards. Practical indicators might include the proportion of women with an abnormal result who attend the recommended assessment, and the time from screening result to diagnostic conclusion, reviewed at regular intervals by providers and health authorities so that tracking informs management.
A recent Saudi primary-care quality improvement study shows what this can look like in practice. At the Armed Forces Hospital in Dhahran, the team reviewed regular reports on mammography requests, completed examinations, results and waiting times to adjust capacity and scheduling as demand changed, and waiting times improved following those adjustments. The study does not show that every subsequent investigation was completed, but it illustrates how information can guide capacity decisions, and why outreach, referrals and service capacity are best planned together, with primary care, diagnostic services and patient-support teams involved before a campaign begins.
The WHO Global Breast Cancer Initiative places timely diagnosis alongside early detection and comprehensive treatment, with a goal of completing diagnostic evaluation, imaging, tissue sampling and pathology within 60 days. This provides a system-planning reference, while clinical assessment determines individual urgency.
Monitoring should include women still waiting, not only those whose investigations are complete. It should also examine differences across locations, entry points and population groups where data permit. An overall improvement can coexist with persistent barriers for particular communities.
Also read: Zambia Medical City Project Advances Through UAE–Zambia Partnership
Turn October’s momentum into lasting capacity
Breast Cancer Awareness Month can strengthen more than participation. It can help health systems test referral arrangements, identify capacity constraints, improve information exchange and establish support that continues throughout the year. Strengthening a health system means building capabilities that remain in place once a campaign ends, because diagnostic responsibility does not end when October does.
Clear responsibility for every abnormal result, across organisational boundaries.
Navigation that continues until the recommended assessment is complete and the outcome has been explained, tracking through diagnostic completion, including women still waiting, so capacity and support can follow need. For every woman whose mammogram requires another step, the health system should be able to offer a clear route forward (and know whether she reached it).
